A great honor to present CoVasc-ICH at the #ESOC2025, establishing the feasibility of testing colchicine in acute ICH. The efficacy and safety of colchicine will be formally tested in the upcoming CoVasc-ICH 2. Ashkan Shoamanesh European Stroke Org PHRI.ca Population Health Research Institute 🇨🇦 McMaster University Department of Medicine

Day 3 #ESOC2025 Canadian Stroke Consortium European Stroke Org Amazing 10 Trials presented today, Congratulations to all the investigators. #stroke #strokecare #prehospital #Neurology

🇮🇹 we sowed well… it took time but the topic is becoming known 🥳 -J Stroke Cerebrovasc Dis. 2015 Feb;24(2):394-400. - advances.umw.edu.pl/pdf/2019/28/2/… - Neurol Sci. 2022Feb;43(2):1127-1134 - ahajournals.org/doi/pdf/10.116… 🔜 Results of FibER TRIAL is coming…💉🧠 NCT05300672 Stroke AHA/ASA

🎓Join our #June webinar series by World Stroke Academy: 🟢 Neuroimaging in Stroke – June 5 🟢 EVT Workshop (Paraguay) – June 11 🟢 #ESOC2025 Joint Roundtable European Stroke Org Stroke AHA/ASA - June 12 🔗Learn more & Register: world-stroke-academy.org #StrokeEducation #StrokeCare

Day 3 #ESOC2025 Prespecified sub analysis of CONVINCE trial according to the CRP levels (<2 mg/dl vs. ≥2 mg/dl). There may be role for tailored trials in secondary stroke prevention using inflammatory biomarkers and Colchicine #stroke #Neurology #Neurotwitter

Ophthalmologist Dr. Edsel Ing and his team have created software to partially restore peripheral vision for people affected by stroke and other brain injuries. Read via Folio: bit.ly/4kz0cD1

May 26-30 is Alberta Rural Health Week. We would like to acknowledge and amplify the tireless work of our rural colleagues across the province. These health care professionals support the health of their patients and strengthen communities. Thank you.

Pleasure to a provide a neurosurgical perspective at CNSF Advances in Movement Disorders course. Great session with my neurology colleagues! #CNSF #2025CNSF

Special Report by Shadi Yaghi et al.: The ISPS25 classification system creates a new framework to understand #stroke etiology and permit targeted treatments and rational randomized trial design for various ischemic stroke subtypes. #AHAJournals #WSC2025 ahajrnls.org/472BjvF

#WSC2025 #ANGELCOAST 👉🏻 BAO <24 hs, NIHSS>10 PC-ASPECT >6 🇨🇳 👉🏻Stent vs aspiration (CA) ✅ CA > 104% FPE 🔴 CA < complete recanalization rates 🟡 No difference in functional and safety outcomes

Day 2 Plenary Session Trials presented #WSC2025 Canadian Stroke Consortium Congratulations, Dr Sylaja PN, for receiving the Presidential Award

Day 3 Plenary Trials #WSC2025 Canadian Stroke Consortium, congratulations to all the investigators, amazing work